Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2000 | |
| Sales | 26,520 |
| Gross Profit | 26,520 |
| Operating Expenses | 39,780 |
| Operating Income | -13,260 |
| Interest Expense | 390 |
| Pre-tax Income | -13,650 |
| Income Tax | 20 |
| Net Income Continuous | -13,670 |
| Net Income | $-13,670 |
| EPS Basic Total Ops | -881.46 |
| EPS Basic Continuous Ops | -881.46 |
| EBITDA(a) | $-13,260 |